Vitestro starts largest-scale clinical trial globally for it

Vitestro, expert in medical robotics, has launched the A.D.O.P.T. Trial for its autonomous blood drawing device (image). With an anticipated sample size of over 10,000 patients, this is the most significant study globally to date of autonomous blood collection. Vitestro expects to obtain CE marking by the end of 2024.

Related Keywords

Netherlands , Amsterdam , Noord Holland , Dordrecht , Zuid Holland , Michael Fouraux , Toon Overbeeke , Albert Schweitzer , Albert Schweizer Ziekenhuis , Communications Consultant Spokesperson , Autonomous Optimization , Performance Tests , Blood Testing , Result Laboratorium , Schweitzer Hospital , Albert Schweitzer Hospital , Antonius Hospital , Principal Investigator , Outpatient Blood Draw , Southwest Netherlands , Amphia Hospital , Beatrix Hospital , Communications Manager , Schweizer Ziekenhuis , Communications Consultant , The Netherlands , 3d Reconstruction , Aboratorium , Result , T Antonius Hospital , Medical Robotics ,